Office of NHS cancer screening programme misrepresents Nordic work in breast screening row

doi:10.1136/bmj.323.7321.1131/a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Peter C Gøtzsche, director (pcg@cochrane.dk)

Nordic Cochrane Centre, Rigshospitalet, DK-2100 Copenhagen ø, Denmark

EDITOR—In Mayor's news story in the issue of 27 October the office of the NHS cancer screening programme in the United Kingdom misrepresents our research entirely.1 The office says that our findings of more aggressive treatment of breast cancer among screened women are based on only two studies, classified as poor quality. They are not. Numbers of mastectomies as well as numbers of tumourectomies increase when women are screened. This finding is consistent and is based on all four of the seven screening trials that have published data on this, including the two medium quality trials from Canada and Malmö.2

The office …